High-Density Lipoprotein Subfractions: Much Ado about Nothing or Clinically Important?

Area of Science:

• Cardiovascular Medicine
• Biochemistry
• Lipidomics

Background:

• High-density lipoproteins (HDL) are complex plasma molecules with diverse lipid and protein compositions.
• HDL's total amount is inversely correlated with coronary heart disease (CHD) risk, prompting interest in its subclasses.
• Understanding HDL heterogeneity is crucial for refining cardiovascular risk prediction.

Purpose of the Study:

• To review the clinical significance of specific high-density lipoprotein (HDL) subgroups.
• To explore the potential of quantifying HDL subclasses for individual coronary heart disease (CHD) risk assessment.
• To discuss the clinical relevance of classifying HDL subgroups for future therapeutic strategies.

Main Methods:

• Literature review of recent clinical findings on HDL subclassifications.
• Analysis of the functional roles and clinical associations of different HDL subgroups.
• Discussion of the implications of HDL subclassification for personalized medicine.

Main Results:

• HDL encompasses a wide spectrum of subclasses with varying lipid and protein content.
• Certain HDL subgroups may possess distinct protective or detrimental effects regarding CHD.
• Current evidence on the clinical utility of measuring HDL subclasses is under evaluation.

Conclusions:

• HDL heterogeneity presents both challenges and opportunities for cardiovascular risk stratification.
• Quantifying specific HDL subgroups could enhance the accuracy of predicting individual CHD risk.
• Future research may enable targeted pharmacological interventions to modulate beneficial HDL subclasses, reducing CHD risk.